Improving Emergency Medicine Patient Care
For Questions Or To Order, Call
800-249-5770
Mon-Fri 8am-5pm EST
View Full Site
Home Browse Articles CME Tests Login
Subscribe Visit Store View Cart

Home > EB Store > Emergency Medicine Practice single issues > Evidence-Based Guidelines For Evaluation And Antimicrobial Therapy For Common Emergency Department Infections


Enlarge Image
Delivery Method:
Mail
Immediate Online Download

Evidence-Based Guidelines For Evaluation And Antimicrobial Therapy For Common Emergency Department Infections - $30.00

Publication Date

January 2012 (Volume 14, Number 1)

CME

This issue includes 4 AMA PRA Category 1 CreditsTM,  4 ACEP Category 1 credits, 4 AAFP Prescribed credits, and 4 AOA Category 2A or 2B CME credits.

Authors

Denise Nassisi, MD
Department of Emergency Medicine, Mount Sinai School of Medicine, New York, NY

Marisa L. Oishi, MD, MPH
Department of Emergency Medicine, Weill Medical College of Cornell University, The Brooklyn Hospital Center, Brooklyn, NY

Peer Reviewers

Peter DeBlieux, MD, FACEP, FAAEM
Louisiana State University Health Science Center Professor of Clinical Medicine, LSUHSC Interim Public Hospital Director of Emergency Medicine Services, LSUHSC Emergency Medicine Director of Faculty and Resident Development, New Orleans, LA

Shkelzen Hoxhaj, MD
Chief of Emergency Medicine, Baylor College of Medicine, Houston, TX

Abstract

Infections are among the most common diagnoses in the emergency department (ED), and antibiotics are among the most frequently prescribed drugs. Community-acquired pneumonia (CAP) and healthcare-associated pneumonia (HCAP) are frequently encountered in the ED, and pneumonia is the seventh leading cause of death in the United States. Cystitis, pyelonephritis, and complicated urinary tract infection (UTI) are often treated in the ED, with UTI being one of the most common reasons for healthy young women to require antimicrobial treatment. Intra-abdominal infections have an incidence of 3.5 million cases per year in the United States, and emergency clinicians must make complex decisions regarding appropriate evaluation and management. Skin and soft-tissue infections (SSTIs) are common, their incidence in the ED has been rising, and the emergence of methicillin-resistant Staphylococcus aureus (MRSA) infection has altered their management. Timely diagnosis and management of infectious disease, including proper antimicrobial treatment, is an important goal of emergency care. This issue of Emergency Medicine Practice reviews the available evidence and consensus guidelines for the management of common infectious diseases presenting to the ED and presents recommendations for treatment.